Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Resminostat> ?p ?o }
Showing triples 1 to 61 of
61
with 100 triples per page.
- Resminostat abstract "Resminostat (4SC-201 or RAS2410) is an orally bioavailable inhibitor of histone deacetylases (HDACs), of which inhibitors are antineoplastic agents.In 2011, the German drug maker 4SC was granted orphan drug designation for resminostat by the Food and Drug Administration for the treatment of hepatocellular carcinoma (HCC).In 2016 the FDA granted [another?] IND for clinical tests in combination with sorafenib for HCC. 4SC say \"In several phase I and phase II trials, resminostat has already demonstrated very good safety and tolerability, alongside promising indications of efficacy.\"".
- Resminostat iupacName "(2E)-3-[1-({4-[(Dimethylamino)methyl]phenyl}sulfonyl)-1H-pyrrol-3-yl]-N-hydroxyacrylamide".
- Resminostat thumbnail Resminostat.svg?width=300.
- Resminostat wikiPageID "43679396".
- Resminostat wikiPageLength "3647".
- Resminostat wikiPageOutDegree "22".
- Resminostat wikiPageRevisionID "708082960".
- Resminostat wikiPageWikiLink PKB_signaling_pathway.
- Resminostat wikiPageWikiLink Apoptosis.
- Resminostat wikiPageWikiLink Bcl-2-associated_X_protein.
- Resminostat wikiPageWikiLink Bcl-xL.
- Resminostat wikiPageWikiLink Category:Histone_deacetylase_inhibitors.
- Resminostat wikiPageWikiLink Category:Hydroxamic_acids.
- Resminostat wikiPageWikiLink Category:Sulfonamides.
- Resminostat wikiPageWikiLink Cell_division.
- Resminostat wikiPageWikiLink Chemotherapy.
- Resminostat wikiPageWikiLink Chromatin_remodeling.
- Resminostat wikiPageWikiLink EIF4EBP1.
- Resminostat wikiPageWikiLink Food_and_Drug_Administration.
- Resminostat wikiPageWikiLink Hepatocellular_carcinoma.
- Resminostat wikiPageWikiLink Histone.
- Resminostat wikiPageWikiLink Histone_deacetylase.
- Resminostat wikiPageWikiLink Investigational_New_Drug.
- Resminostat wikiPageWikiLink Orphan_drug.
- Resminostat wikiPageWikiLink P70S6_kinase.
- Resminostat wikiPageWikiLink Phosphorylation.
- Resminostat wikiPageWikiLink Pracinostat.
- Resminostat wikiPageWikiLink Sorafenib.
- Resminostat wikiPageWikiLink Transcription_(genetics).
- Resminostat wikiPageWikiLinkText "Resminostat".
- Resminostat wikiPageWikiLinkText "resminostat".
- Resminostat imagefile "Resminostat.svg".
- Resminostat imagesize "250".
- Resminostat iupacname "-3".
- Resminostat name "Resminostat".
- Resminostat othernames "RAS2410; Resminostat 4SC-201".
- Resminostat wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Resminostat wikiPageUsesTemplate Template:Chembox.
- Resminostat wikiPageUsesTemplate Template:Chembox_Hazards.
- Resminostat wikiPageUsesTemplate Template:Chembox_Identifiers.
- Resminostat wikiPageUsesTemplate Template:Chembox_Properties.
- Resminostat wikiPageUsesTemplate Template:Fdacite.
- Resminostat wikiPageUsesTemplate Template:Reflist.
- Resminostat subject Category:Histone_deacetylase_inhibitors.
- Resminostat subject Category:Hydroxamic_acids.
- Resminostat subject Category:Sulfonamides.
- Resminostat hypernym Agents.
- Resminostat type ChemicalCompound.
- Resminostat type ChemicalSubstance.
- Resminostat type ChemicalObject.
- Resminostat type Thing.
- Resminostat type Q11173.
- Resminostat comment "Resminostat (4SC-201 or RAS2410) is an orally bioavailable inhibitor of histone deacetylases (HDACs), of which inhibitors are antineoplastic agents.In 2011, the German drug maker 4SC was granted orphan drug designation for resminostat by the Food and Drug Administration for the treatment of hepatocellular carcinoma (HCC).In 2016 the FDA granted [another?] IND for clinical tests in combination with sorafenib for HCC.".
- Resminostat label "Resminostat".
- Resminostat sameAs Q18394103.
- Resminostat sameAs m.011q7668.
- Resminostat sameAs Q18394103.
- Resminostat wasDerivedFrom Resminostat?oldid=708082960.
- Resminostat depiction Resminostat.svg.
- Resminostat isPrimaryTopicOf Resminostat.
- Resminostat name "Resminostat".